Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial
U Ricardi, AR Filippi, A Guarneri, FR Giglioli… - Lung cancer, 2010 - Elsevier
Patients affected with early stage (IA–IB) non-small cell lung cancer (NSCLC), deemed
medically inoperable, are usually treated by conventional 3D-CRT, with poor results in terms …
medically inoperable, are usually treated by conventional 3D-CRT, with poor results in terms …
Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: Phase I study
RC McGarry, L Papiez, M Williams, T Whitford… - International Journal of …, 2005 - Elsevier
Purpose: A Phase I dose escalation study of stereotactic body radiation therapy to assess
toxicity and local control rates for patients with medically inoperable Stage I lung cancer …
toxicity and local control rates for patients with medically inoperable Stage I lung cancer …
Stereotactic body radiation therapy for early-stage non–small-cell lung carcinoma: four-year results of a prospective phase II study
AJ Fakiris, RC McGarry, CT Yiannoutsos… - International Journal of …, 2009 - Elsevier
PURPOSE: The 50-month results of a prospective Phase II trial of stereotactic body radiation
therapy (SBRT) in medically inoperable patients are reported. METHODS AND MATERIALS …
therapy (SBRT) in medically inoperable patients are reported. METHODS AND MATERIALS …
[HTML][HTML] Stereotactic body radiation therapy for non-small cell lung cancer: A review
KM Prezzano, SJ Ma, GM Hermann… - World journal of …, 2019 - ncbi.nlm.nih.gov
Stereotactic body radiation therapy (SBRT) is the treatment of choice for medically
inoperable patients with early stage non-small cell lung cancer (NSCLC). A literature search …
inoperable patients with early stage non-small cell lung cancer (NSCLC). A literature search …
A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer
M Koto, Y Takai, Y Ogawa, H Matsushita… - Radiotherapy and …, 2007 - Elsevier
BACKGROUND AND PURPOSE: The outcome of stage I non-small cell lung cancer
(NSCLC) patients treated with conventional radiotherapy is inferior to that of patients treated …
(NSCLC) patients treated with conventional radiotherapy is inferior to that of patients treated …
Stereotactic body radiation therapy for early-stage non–small-cell lung cancer: the pattern of failure is distant
JD Bradley, I El Naqa, RE Drzymala, M Trovo… - International Journal of …, 2010 - Elsevier
BACKGROUND: Stereotactic body radiation therapy (SBRT) represents a substantial
paradigm shift in the treatment of patients with medically inoperable Stage I/II non–small-cell …
paradigm shift in the treatment of patients with medically inoperable Stage I/II non–small-cell …
Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients
M Taremi, A Hope, M Dahele, S Pearson… - International Journal of …, 2012 - Elsevier
PURPOSE: To present the results of stereotactic body radiotherapy (SBRT) for medically
inoperable patients with Stage I non–small-cell lung cancer (NSCLC) and contrast outcomes …
inoperable patients with Stage I non–small-cell lung cancer (NSCLC) and contrast outcomes …
Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non–small-cell lung cancer
JY Chang, PA Balter, L Dong, Q Yang, Z Liao… - International Journal of …, 2008 - Elsevier
PURPOSE: To evaluate the efficacy and adverse effects of image-guided stereotactic body
radiation therapy (SBRT) in centrally/superiorly located non–small-cell lung cancer …
radiation therapy (SBRT) in centrally/superiorly located non–small-cell lung cancer …
Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non–small-cell lung cancer: results of a phase II trial
S Bral, T Gevaert, N Linthout, H Versmessen… - International Journal of …, 2011 - Elsevier
PURPOSE: Validation of a prospective, risk-adapted strategy for early-stage non–small-cell
lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT) …
lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT) …
Stereotactic body radiotherapy (SBRT) for operable stage I non–small-cell lung cancer: can SBRT be comparable to surgery?
PURPOSE: To review treatment outcomes for stereotactic body radiotherapy (SBRT) in
medically operable patients with Stage I non–small-cell lung cancer (NSCLC), using a …
medically operable patients with Stage I non–small-cell lung cancer (NSCLC), using a …